342 related articles for article (PubMed ID: 29669936)
1. Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model.
Jin BY; Campbell TE; Draper LM; Stevanović S; Weissbrich B; Yu Z; Restifo NP; Rosenberg SA; Trimble CL; Hinrichs CS
JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669936
[TBL] [Abstract][Full Text] [Related]
2. HLA-class II restricted TCR targeting human papillomavirus type 18 E7 induces solid tumor remission in mice.
Long J; Chen X; He M; Ou S; Zhao Y; Yan Q; Ma M; Chen J; Qin X; Zhou X; Chu J; Han Y
Nat Commun; 2024 Mar; 15(1):2271. PubMed ID: 38480731
[TBL] [Abstract][Full Text] [Related]
3. Dual T cell receptor/chimeric antigen receptor engineered NK-92 cells targeting the HPV16 E6 oncoprotein and the tumor-associated antigen L1CAM exhibit enhanced cytotoxicity and specificity against tumor cells.
Quiros-Fernandez I; Libório-Ramos S; Leifert L; Schönfelder B; Vlodavsky I; Cid-Arregui A
J Med Virol; 2024 May; 96(5):e29630. PubMed ID: 38659368
[TBL] [Abstract][Full Text] [Related]
4. Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy.
Manzar GS; Alam MBE; Lynn EJ; Karpinets TV; Harris T; Lo D; Yoshida-Court K; Napravnik TC; Sammouri J; Lin D; Andring LM; Bronk J; Wu X; Sims TT; Mathew G; Schmeler KM; Eifel PJ; Jhingran A; Lin LL; Joyner MM; Zhang J; Futreal A; Klopp AH; Colbert LE
Brachytherapy; 2024; 23(2):123-135. PubMed ID: 38129211
[TBL] [Abstract][Full Text] [Related]
5. Whole-Genome Analysis of Cervical Human Papillomavirus Type 35 from rural Zimbabwean Women.
Fitzpatrick MB; Hahn Z; Mandishora RSD; Dao J; Weber J; Huang C; Sahoo MK; Katzenstein DA; Pinsky BA
Sci Rep; 2020 Apr; 10(1):7001. PubMed ID: 32332798
[TBL] [Abstract][Full Text] [Related]
6. In vivo cervical cancer growth inhibition by genetically engineered cytotoxic T cells.
Dall P; Herrmann I; Durst B; Stoff-Khalili MA; Bauerschmitz G; Hanstein B; Niederacher D
Cancer Immunol Immunother; 2005 Jan; 54(1):51-60. PubMed ID: 15693139
[TBL] [Abstract][Full Text] [Related]
7. Tsyn-Seq: a T-cell Synapse-Based Antigen Identification Platform.
Jin Y; Miyama T; Brown A; Hayase T; Song X; Singh AK; Huang L; Flores II; McDaniel LK; Glover I; Halsey TM; Prasad R; Chapa V; Ahmed S; Zhang J; Rai K; Peterson CB; Lizee G; Karmouch J; Hayase E; Molldrem JJ; Chang CC; Tsai WB; Jenq RR
Cancer Immunol Res; 2024 May; 12(5):530-543. PubMed ID: 38363296
[TBL] [Abstract][Full Text] [Related]
8. A Mathematical Model of TCR-T Cell Therapy for Cervical Cancer.
Wang Z; Cho H; Choyke P; Levy D; Sato N
Bull Math Biol; 2024 Apr; 86(5):57. PubMed ID: 38625492
[TBL] [Abstract][Full Text] [Related]
9. "Digital twins elucidate critical role of T
Joslyn LR; Huang W; Miles D; Hosseini I; Ramanujan S
NPJ Syst Biol Appl; 2024 Jan; 10(1):11. PubMed ID: 38278838
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain Metastases.
Mehta GU; Malekzadeh P; Shelton T; White DE; Butman JA; Yang JC; Kammula US; Goff SL; Rosenberg SA; Sherry RM
J Immunother; 2018 Jun; 41(5):241-247. PubMed ID: 29672342
[TBL] [Abstract][Full Text] [Related]
11. A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial Cancers.
Stevanović S; Helman SR; Wunderlich JR; Langhan MM; Doran SL; Kwong MLM; Somerville RPT; Klebanoff CA; Kammula US; Sherry RM; Yang JC; Rosenberg SA; Hinrichs CS
Clin Cancer Res; 2019 Mar; 25(5):1486-1493. PubMed ID: 30518633
[TBL] [Abstract][Full Text] [Related]
12. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer.
Zacharakis N; Chinnasamy H; Black M; Xu H; Lu YC; Zheng Z; Pasetto A; Langhan M; Shelton T; Prickett T; Gartner J; Jia L; Trebska-McGowan K; Somerville RP; Robbins PF; Rosenberg SA; Goff SL; Feldman SA
Nat Med; 2018 Jun; 24(6):724-730. PubMed ID: 29867227
[TBL] [Abstract][Full Text] [Related]
13. Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy.
Yossef R; Tran E; Deniger DC; Gros A; Pasetto A; Parkhurst MR; Gartner JJ; Prickett TD; Cafri G; Robbins PF; Rosenberg SA
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282837
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.
Garfall AL; Stadtmauer EA; Hwang WT; Lacey SF; Melenhorst JJ; Krevvata M; Carroll MP; Matsui WH; Wang Q; Dhodapkar MV; Dhodapkar K; Das R; Vogl DT; Weiss BM; Cohen AD; Mangan PA; Ayers EC; Nunez-Cruz S; Kulikovskaya I; Davis MM; Lamontagne A; Dengel K; Kerr ND; Young RM; Siegel DL; Levine BL; Milone MC; Maus MV; June CH
JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669947
[TBL] [Abstract][Full Text] [Related]
15. Antigen Presentation Keeps Trending in Immunotherapy Resistance.
Kalbasi A; Ribas A
Clin Cancer Res; 2018 Jul; 24(14):3239-3241. PubMed ID: 29674509
[TBL] [Abstract][Full Text] [Related]
16. Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma.
Kalaora S; Wolf Y; Feferman T; Barnea E; Greenstein E; Reshef D; Tirosh I; Reuben A; Patkar S; Levy R; Quinkhardt J; Omokoko T; Qutob N; Golani O; Zhang J; Mao X; Song X; Bernatchez C; Haymaker C; Forget MA; Creasy C; Greenberg P; Carter BW; Cooper ZA; Rosenberg SA; Lotem M; Sahin U; Shakhar G; Ruppin E; Wargo JA; Friedman N; Admon A; Samuels Y
Cancer Discov; 2018 Nov; 8(11):1366-1375. PubMed ID: 30209080
[TBL] [Abstract][Full Text] [Related]
17. Understanding the tumor immune microenvironment (TIME) for effective therapy.
Binnewies M; Roberts EW; Kersten K; Chan V; Fearon DF; Merad M; Coussens LM; Gabrilovich DI; Ostrand-Rosenberg S; Hedrick CC; Vonderheide RH; Pittet MJ; Jain RK; Zou W; Howcroft TK; Woodhouse EC; Weinberg RA; Krummel MF
Nat Med; 2018 May; 24(5):541-550. PubMed ID: 29686425
[TBL] [Abstract][Full Text] [Related]
18. Systems Immunology: Learning the Rules of the Immune System.
Villani AC; Sarkizova S; Hacohen N
Annu Rev Immunol; 2018 Apr; 36():813-842. PubMed ID: 29677477
[TBL] [Abstract][Full Text] [Related]
19. Unraveling the Complex Interplay Between T Cell Metabolism and Function.
Geltink RIK; Kyle RL; Pearce EL
Annu Rev Immunol; 2018 Apr; 36():461-488. PubMed ID: 29677474
[TBL] [Abstract][Full Text] [Related]
20. Transcript-indexed ATAC-seq for precision immune profiling.
Satpathy AT; Saligrama N; Buenrostro JD; Wei Y; Wu B; Rubin AJ; Granja JM; Lareau CA; Li R; Qi Y; Parker KR; Mumbach MR; Serratelli WS; Gennert DG; Schep AN; Corces MR; Khodadoust MS; Kim YH; Khavari PA; Greenleaf WJ; Davis MM; Chang HY
Nat Med; 2018 May; 24(5):580-590. PubMed ID: 29686426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
